Details of the Drug
General Information of Drug (ID: DMDM3Y1)
Drug Name |
Immepip
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Immepip; 151070-83-6; 4-(1H-Imidazol-4-ylmethyl)piperidine; 4-(1H-imidazol-5-ylmethyl)piperidine; CHEBI:81390; Piperidine,4-(1H-imidazol-5-ylmethyl)-; 4-(1H-Imidazol-4-ylmethyl)-piperidine; 4-((1H-imidazol-4-yl)methyl)piperidine; Immepip, Dihydrobromide; 4-IMP; Tocris-0932; AC1MI02O; CHEMBL18661; ACMC-20n643; ZINC5777; SCHEMBL3338054; GTPL1251; BDBM22542; CTK4C6867; DTXSID10164703; FCH842654; BDBM50150945; AKOS006273473; AKOS015964158; 4-(3H-imidazol-4-ylmethyl)piperidine; NCGC00024883-01; NCGC00024883-02; CC-16184; KB-33506
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 165.24 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 0.7 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References